Sethuraman Natarajan
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Sethuraman Natarajan. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| TRDA | President, Research & Develop. | Tax Withholding | 1,760 | $5.43 | $9,557 | Sep 2, 2025 |
| TRDA | President, Research & Develop. | Award / Grant | 60,800 | — | — | Mar 3, 2025 |
| TRDA | President, Research & Develop. | Sale | 4,088 | $20.26 | $82,823 | Nov 29, 2024 |
| TRDA | President, Research & Develop. | Sale | 2,700 | $20.04 | $54,108 | Nov 11, 2024 |
| TRDA | President, Research & Develop. | Sale | 5,171 | $18.18 | $94,009 | Nov 4, 2024 |
| TRDA | President, Research & Develop. | Sale | 600 | $18.00 | $10,800 | Oct 16, 2024 |
| TRDA | Chief Scientific Officer | Sale | 600 | $15.24 | $9,144 | Sep 9, 2024 |
| TRDA | Chief Scientific Officer | Tax Withholding | 14 | $17.70 | $248 | Sep 3, 2024 |
| TRDA | Chief Scientific Officer | Sale | 638 | $18.00 | $11,484 | Jul 12, 2024 |
| TRDA | Chief Scientific Officer | Sale | 9,675 | $15.19 | $146,963 | May 16, 2024 |
| TRDA | Chief Scientific Officer | Tax Withholding | 1,505 | $12.28 | $18,481 | Mar 1, 2024 |
| TRDA | Chief Scientific Officer | Award / Grant | 14,200 | — | — | Sep 5, 2023 |
| TRDA | Chief Scientific Officer | Sale | 14,852 | $18.04 | $267,930 | Jul 10, 2023 |
| TRDA | Chief Scientific Officer | Sale | 3,961 | $18.00 | $71,298 | Apr 17, 2023 |
| TRDA | Chief Scientific Officer | Tax Withholding | 1,058 | $11.60 | $12,273 | Mar 1, 2023 |
| TRDA | Chief Scientific Officer | Award / Grant | 14,200 | — | — | Mar 1, 2023 |
| TRDA | Chief Scientific Officer | Award / Grant | 5,794 | — | — | Sep 1, 2022 |
| TRDA | Chief Scientific Officer | Award / Grant | 11,588 | — | — | Mar 1, 2022 |